Peter Allacher

612 total citations
15 papers, 491 citations indexed

About

Peter Allacher is a scholar working on Hematology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter Allacher has authored 15 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Immunology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter Allacher's work include Hemophilia Treatment and Research (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Platelet Disorders and Treatments (5 papers). Peter Allacher is often cited by papers focused on Hemophilia Treatment and Research (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Platelet Disorders and Treatments (5 papers). Peter Allacher collaborates with scholars based in Austria, United States and Germany. Peter Allacher's co-authors include Birgit M. Reipert, Frank Horling, Johannes Oldenburg, Jerzy Windyga, Christoph J. Hofbauer, Andreas Tiede, Friedrich Scheiflinger, Christoph Male, Martin J. Wolfsegger and Jürgen Siekmann and has published in prestigious journals such as Blood, Pharmaceutical Research and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

Peter Allacher

15 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Allacher Austria 9 305 120 105 91 75 15 491
Frank Horling Austria 10 316 1.0× 232 1.9× 101 1.0× 89 1.0× 70 0.9× 18 658
Nicole J. Bernshaw United States 8 252 0.8× 157 1.3× 49 0.5× 440 4.8× 116 1.5× 16 729
M. Graham United States 4 80 0.3× 118 1.0× 31 0.3× 36 0.4× 46 0.6× 7 311
Delphine Nigon France 12 71 0.2× 177 1.5× 31 0.3× 121 1.3× 35 0.5× 21 492
Emily K. Waters United States 9 251 0.8× 206 1.7× 16 0.2× 49 0.5× 104 1.4× 18 457
Jennifer Sun United States 9 126 0.4× 138 1.1× 50 0.5× 146 1.6× 13 0.2× 17 373
Aviva C. Krauss United States 9 159 0.5× 155 1.3× 16 0.2× 84 0.9× 34 0.5× 20 442
Sarah H. Beachy United States 12 85 0.3× 219 1.8× 17 0.2× 84 0.9× 23 0.3× 22 443
G. Vierwinden Netherlands 11 60 0.2× 117 1.0× 100 1.0× 115 1.3× 18 0.2× 14 390
Shanmugapriya Thangavadivel United States 9 141 0.5× 109 0.9× 182 1.7× 186 2.0× 25 0.3× 17 495

Countries citing papers authored by Peter Allacher

Since Specialization
Citations

This map shows the geographic impact of Peter Allacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Allacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Allacher more than expected).

Fields of papers citing papers by Peter Allacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Allacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Allacher. The network helps show where Peter Allacher may publish in the future.

Co-authorship network of co-authors of Peter Allacher

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Allacher. A scholar is included among the top collaborators of Peter Allacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Allacher. Peter Allacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Horling, Frank, Birgit M. Reipert, Peter Allacher, et al.. (2024). Immunogenicity profile of rurioctocog alfa pegol in previously treated patients with severe congenital hemophilia A. Blood Advances. 8(11). 2726–2739. 2 indexed citations
2.
Hofbauer, Christoph J., Peter Allacher, Karl Zwiauer, et al.. (2021). Nonneutralizing FVIII-specific antibody signatures in patients with hemophilia A and in healthy donors. Blood Advances. 6(3). 946–958. 9 indexed citations
3.
Jaki, Thomas, Peter Allacher, & Frank Horling. (2016). A false sense of security? Can tiered approach be trusted to accurately classify immunogenicity samples?. Journal of Pharmaceutical and Biomedical Analysis. 128. 166–173. 6 indexed citations
4.
Allacher, Peter, Maurus de la Rosa, Alexander Bauer, et al.. (2016). The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?. Pharmaceutical Research. 33(9). 2239–2249. 136 indexed citations
5.
Horling, Frank, Peter Allacher, Herwig Koppensteiner, et al.. (2016). Immunogenicity of BAX 855 in Previously Treated Patients with Congenital Severe Hemophilia Α. Blood. 128(22). 2594–2594. 1 indexed citations
6.
Hofbauer, Christoph J., Peter Allacher, Frank Horling, et al.. (2014). Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans. Blood. 125(7). 1180–1188. 98 indexed citations
7.
Jaki, Thomas, John‐Philip Lawo, Martin J. Wolfsegger, Peter Allacher, & Frank Horling. (2013). A comparison of methods for classifying samples as truly specific with confirmatory immunoassays. Journal of Pharmaceutical and Biomedical Analysis. 88. 27–35. 4 indexed citations
8.
Hofbauer, Christoph J., Frank Horling, Peter Allacher, et al.. (2012). Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients. Blood. 121(6). 1039–1048. 136 indexed citations
9.
Jaki, Thomas, John‐Philip Lawo, Martin J. Wolfsegger, et al.. (2011). A formal comparison of different methods for establishing cut points to distinguish positive and negative samples in immunoassays. Journal of Pharmaceutical and Biomedical Analysis. 55(5). 1148–1156. 21 indexed citations
10.
Baumgartner, Christina K., Peter Allacher, Rafi U. Ahmad, et al.. (2011). T cell–independent restimulation of FVIII-specific murine memory B cells is facilitated by dendritic cells together with toll-like receptor 7 agonist. Blood. 118(11). 3154–3162. 14 indexed citations
11.
Reipert, Birgit M., Peter Allacher, Christina Hausl, et al.. (2010). Modulation of factor VIII‐specific memory B cells. Haemophilia. 16(102). 25–34. 19 indexed citations
12.
Allacher, Peter, et al.. (2010). Stimulation and inhibition of FVIII-specific memory B-cell responses by CpG-B (ODN 1826), a ligand for Toll-like receptor 9. Blood. 117(1). 259–267. 19 indexed citations
13.
Hausl, Christina, Peter Allacher, Rafi U. Ahmad, et al.. (2008). Requirements for Co-Stimulation in T-Cell Dependent and T-Cell Independent Re-Stimulation of FVIII-Specific Memory B Cells. Blood. 112(11). 238–238. 18 indexed citations
14.
Hausl, Christina, Peter Allacher, Rafi U. Ahmad, et al.. (2007). T-Cell-Independent Re-Stimulation of FVIII-Specific Memory B Cells Requires Help from Activated Plasmacytoid Dendritic Cells.. Blood. 110(11). 1155–1155. 1 indexed citations
15.
Allacher, Peter, Christina Hausl, Rafi U. Ahmad, et al.. (2005). Toll-Like Receptor Triggering Modulates Factor VIII-Specific Immune Memory in Murine Hemophilia A with Factor VIII Inhibitors.. Blood. 106(11). 214–214. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026